E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/19/2011 in the Prospect News PIPE Daily.

FluoroPharma completes $1.01 million private placement of its shares

Investors in offering also receive warrants for 425,904 common shares

By Devika Patel

Knoxville, Tenn., Dec. 19 - FluoroPharma Medical, Inc. settled a $1.01 million private placement of stock on Dec. 13, according to an 8-K filed Monday with the Securities and Exchange Commission.

The company sold 1,216,868 common shares at $0.83 apiece, a 3.49% discount to the Dec. 13 closing share price of $0.86.

Investors also received warrants for 425,904 shares; the warrants are exercisable $1.33, a 54.65% premium to the Dec. 13 closing share price.

Proceeds will be used for working capital and to invest in new product innovations expected in the first quarter of 2012.

The biopharmaceutical company is based in Boston.

Issuer:FluoroPharma Medical, Inc.
Issue:Common stock
Amount:$1.01 million
Shares:1,216,868
Price:$0.83
Warrants:For 2425,904 shares
Warrant strike price:$1.33
Settlement date:Dec. 13
Stock symbol:OTCBB: FPMI
Stock price:$0.86 at close Dec. 13
Market capitalization:$16.72 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.